Tyrosine kinase-2 (Tyk2) participates in the signaling pathways of multiple cytokines in innate and acquired immunity. In the present study, we investigated in the in vivo involvement of Tyk2 in anti-type II collagen antibody-induced arthritis (CAIA) using Tyk2-deficient mice. Hind paws of wild-type mice showed massive swelling and erythema by arthritogenic antibody injection, while Tyk2 deficient mice did not show any signs of arthritis. Indeed, neither the infiltration of inflammatory cells nor the fibrillation of articular cartilages was observed in Tyk2-deficient mice.
Introduction
Several disorders affect the joints in humans and give rise to chronic arthritis. Among these diseases, rheumatoid arthritis (RA) is one of the most disabling and carefully studied diseases with regards to the tissue-specific attack of diarthrodial joints leading to the destruction of cartilage and bone (1, 2) . However, RA is probably not a single disease, but rather a clinical syndrome caused by a variety of different pathological processes (3) . Disease susceptibility is associated with antigen presentation to T lymphocytes by particular HLA-DR haplotypes (4) .
Also, CD4
+ T cells infiltrating into the RA synovial membrane are predominantly Th1
phenotypes (5, 6) . According to a current paradigm, a pathogenic role of Th1-type cellular immunity is supposed to prevail over a beneficial Th2 response. Therefore, animal models of arthritis provide important tools for the dissection of the various cellular and molecular mechanisms leading to the arthritis of RA. Collagen-induced arthritis (CIA) in mice is widely used as an experimental model for human RA (7) . Treatment of mice with collagens induces autoantibodies, which bind to a particular region of type II collagen (CII). However, arthritogenic epitopes are apparently clustered within a certain region of CII depending upon the MHC types in mice, such as CB11 in DBA/1 (H-2 q ) mice and CB8 in B10.RIII (H-2 r )
mice (8, 9) . Thus, CIA susceptibility is low in C57BL/6 mice and is resistant in BALB/c mice.
The ability to induce arthritis using this arthritogenic antibody cocktail provides an efficient protocol for the induction of anti-CII antibody-induced arthritis (CAIA) that can be applicable for C57BL/6 and BALB/c mice and used as a shorter, more synchronized alternative to the CIA model (9) .
Tyk2, a Jak family of kinases, is activated in response to various cytokines including interferons (IFNs), IL-6, IL-10, IL-12, IL-13, and IL-23 (10) (11) (12) (13) (14) (15) . However, Tyk2 was dispensable for IL-6-and IL-10-mediated signaling in mice (16, 17) . We have reported that
Tyk2 is required for IFN-α/β/-mediated signals to suppress hematopoietic cell growth, but not for those to induce antiviral activities (18, 19) . Thus, the involvement of Tyk2 in IFN-α/β-signaling is restricted. In the case of IL-12-mediated signaling, signals for IFN-γ production by T cells were highly dependent on Tyk2 (16, 17, 20) . Thus, experiments using Tyk2-deficient cells have revealed that a different level of dependence on Tyk2 is evident among several cytokines.
Experimental allergic encephalomyelitis (EAE), which is induced by immunization with myelin antigens or by an adoptive transfer of myelin-specific CD4 + effector cells, is an animal model of human multiple sclerosis (21). Tyk2-deficient mice showed lower scores for erythema, scaling, and thickness in this model (22). Moreover, the involvement of Tyk2 was confirmed by experiments using B10.Q mice carrying different Tyk2 polymorphisms (23, 24) .
A defect in the IL-12 responsiveness of NK and T cells derived from a subline of the B10.Q mouse maintained at The Jackson Laboratory (Bar Harbor, ME; B10.Q/J), unlike B10.Q/Ai mice, their counterparts bred at Taconic Farms (Tarrytown, NY), was serendipitously found (25, 26) and B10.Q/J mice were shown to be highly susceptible to parasite challenge (26) .
Tyk2 cDNA from the spleen of both B10.Q/J mice showed a single missense mutation (G→A substitution) at position 2538 in the B10.Q/J Tyk2 coding region, resulting in a nonconservative amino acid substitution (E775K) in an invariant motif of the pseudokinase (Janus kinase homology 2) domain (23) . This mutation appeared to result in the absence of the B10.Q/J-encoded Tyk2 protein, despite presence of Tyk2-specific transcripts. B10.Q/J mice, which express a Tyk2A allele, were resistant to EAE development and can be compensated by one copy of Tyk2G allele from B10.Q/Ai mice (22). In addition to the EAE model, mice carrying Tyk2 polymorphisms exhibited other susceptibility in a model for CIA (24) . B10.Q/Ai mice were highly susceptible to CIA, while B10.Q/J mice were resistant.
These studies have suggested that deficiency of Tyk2 results in defined clinical disorders.
autoantibodies after collagen-challenge and the inflammatory responses after reactions of autoantibodies to joints. The CAIA model requires only inflammatory responses after a challenge with a cocktail of anti-type II collagen antibodies. Thus, CAIA is a more restricted and simple model than CIA, and is suitable in evaluating inflammatory responses in arthritis.
In the present study, we showed that Tyk2 plays central roles in not only adaptive autoimmunity, but also inflammatory responses in a murine arthritis model. The involvement of Tyk2 in multiple steps of RA development likely suggests that therapeutic targeting of Tyk2 could provide benefits in RA.
Methods

Antibodies and mice
Anti-STAT3, anti-STAT4 and anti-IκBα, antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA); anti-pSTAT3(Tyr705), and anti-pSTAT4(Tyr693)
antibodies from Cell Signaling Technologies (Beverly, MA); anti-actin antibody from Millipore (Billerica, MA). B10.D1-H2q/SgJ (B10.Q/J) mice bearing the Tyk2A allele and B10.Q/Ai mice with the Tyk2G allele were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) and Taconic Farms (Germantown, NY, USA), respectively.
Tyk2-deficient mice were backcrossed for >8 generations onto BALB/c mice (27) . Mice were kept under specific pathogen-free conditions and provided with food and water ad libitum. All experiments were performed according to the guidelines of the Institutional Animal Care and Use Committee of Hokkaido University and Daiichi-Sankyo Co., Ltd.
Induction and assessment of arthritis
In CIA model, B10.Q/Ai or B10.Q/J mice were intradermally immunized at the tail with an emulsion of 150 µg of bovine type II collagen (CII) (Collagen Gijutsu Kensyukai, Tokyo, JAPAN) in complete Freund's adjuvant (CFA) (Difco, MI, USA) (Day 0). On day 21, the mice received booster immunization at the base of the tail. Mice were scored three times per week, beginning 3 weeks after the first immunization, for signs of developing arthritis. The severity of the arthritis was assessed using a visual scoring system. Each paw was scored on a graded scale from 0 to 3: 0, normal paw; 0.5, swelling of one toe joint; 1, swelling of two or more toe joints, or increased swelling; 2, severe swelling; and 3, ankylosis throughout the entire paw. Each paw was graded and the four scores were added such that the maximal score per mouse was 12.
In CAIA model, arthritogenic antibody cocktail was obtained from Chondrex (WA, USA), and arthritis was induced according to the manufacturer's instructions (28) . Briefly, WT or Tyk2 -/-mice were intravenously injected with a mixture of five anti-type II collagen mAbs (6 mg each) on day 0. Severity of the macroscopic levels of arthritis was graded up to 7 days after mAb injection in each of the four limbs per mouse on a 1-4 scale. At the end of the studies, on day 7, paw swelling volumes were quantitatively measured using a plethysmometer (Muromachi Kikai, Tokyo, JAPAN) and collected for histopathology.
Histological techniques
For histological processing, paws were fixed in phosphate buffer containing 10%
formaldehyde and decalcified with EDTA. Paws were processed by routine methods to paraffin blocks. Specimens were sectioned at 6 µm and stained with H&E. The sections were evaluated for the degree of synovial hyperplasia, inflammatory cell infiltrate, cartilage damage, pannus formation, bone erosion, and ankylosis.
Extraction of paw RNA and TaqMan analysis of gene expression
RNA was extracted from cells in paws, which were snap frozen in liquid nitrogen, using ISOGEN (Nippon Gene, Tokyo, Japan) (29) . Using 5 µg of total RNA template, cDNA was prepared using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems, CA, USA). Quantitative real-time PCR analyses of the respective gene, as well as the control GAPDH mRNA transcripts were carried out using TaqMan Gene Expression assay probe/primer mixture and TaqMan Universal Master Mix II. PCR amplification and evaluation were performed using Applied Biosystems 7900HT Fast Real-Time PCR System.
The reverse transcription and PCR conditions were according to the manufacturer's instructions, and PCR was carried up to 40 cycles.
Western blotting
The western blotting assays were performed as described previously (29) . Briefly, three days after CAIA induction, popliteal lymph nodes were collected and 10 6 lymph node cells were lysed in 20 µl of RIPA buffer (Santa Cruz). The cell lysates were resolved on SDS-PAGE and transferred to PVDF transfer membrane (PerkinElmer; Boston, MA). The filters were then immunoblotted with each antibody. Immunoreactive proteins were visualized using an enhanced chemiluminescence detection system (Millipore). Inc., Cary, NC).
Statistical analyses
Results
B10.Q/J mice show a deficient CIA response.
To first reconfirm the pathophysiological significance of Tyk2 in arthritis, we analyzed shown by a photo and by the volume of the hind paw. Hind paws of anti-CII mAbs-injected WT mice showed massive swelling and erythema that extended to the ankle, while those of anti-CII mAbs-injected Tyk2 -/-mice did not (Fig. 2B) . The hind paw volume of WT mice was significantly increased by anti-CII mAbs-injection on day 7, while that of Tyk2 -/-mice did not (Fig. 2C) . Therefore, the development of CAIA completely requires the presence of Tyk2.
Histological features of CAIA in Tyk2-deficient mice
The joints of WT mice frequently showed severe pathology with cartilage and bone erosion, synovial inflammation, and a formation of invasive pannus (Fig. 3) . In contrast, none of the Tyk2 -/-mice were observed to have more than minimal pannus formation or fibrillation of the articular cartilage in the nonarthritic animal. Therefore, the histological analysis of the paws confirmed the involvement of Tyk2 in CAIA.
Real-time PCR analysis of gene expression in paw of mice with CAIA.
Inflammatory arthritis-related genes from cells in paws from Tyk2 -/-and WT mice with or without anti-type CII mAbs-treatment were quantified with real-time PCR analysis after correcting for the GAPDH level in each sample. Paws from the Tyk2 -/-and WT mice were harvested at day 3 and 7 after the induction. As shown in Fig. 4A , the Th1/Th17-related cytokines such as IFN-γ and IL-17, were significantly induced at day3 by anti-CII mAbs-injection in WT mice, whereas expression of these cytokines decreased at day7, indicating that the Th1/Th17-related cytokines are involved in early stage of development of CAIA. Importantly, these cytokines were significantly reduced in Tyk2 -/-mice. The inflammatory cytokines such as IL-6, IL-1β, TNF-α and IFN-β were also induced by anti-CII impaired in Tyk2 -/-mice compared with WT mice. Furthermore, a macrophage marker, F4/80
showed macrophage accumulation was enhanced by anti-CII mAbs-injection in WT mice at day3 and 7 (Fig. 5) . This macrophage accumulation was also impaired in tyk2-deficient mice at day 7. Similarly, a neutrophil maker, elastase showed a reduced accumulation in Tyk2-deficient mice ( Although the early immune responses are surely dependent on Tyk2, its involvement in the latter inflammatory responses remains to be solved. Our main data using the CAIA model clarified that Tyk2 also plays important roles in the inflammatory stages. Indeed, paws from mice received anti-type II mAbs treatment had fewer macrophage/neutrophil infiltration and less pro-inflammatory cytokines and MMPs. This might be in part involved in the impaired expression of CCL2 and CXCL1 chemokines in Tyk2 -/-mice.
CAIA, which is an antibody transfer model, bypasses the T and B cell-dependent events in CIA (9) . Thus, we can analyze innate immune, as well as inflammatory responses after autoantibodies are produced. Indeed, CAIA has been utilized to screen a number of molecules for the treatment of RA. For example, a small molecule (GW2580), which is a low molecular weight inhibitor for c-Fms, was shown to reduce arthritis severity in this model (33) .
MMP-9 -/-mice did not develop severe CAIA (34). As we showed here, Tyk2 -/-mice showed great resistance to developing arthritis in CAIA. Histological analysis indicated that Tyk2 deficiency reduced infiltration of leukocytes and inflammatory cells into the synovium. In addition, Tyk2 -/-mice severely impaired the production of IFN-γ, TNF, IL-6, and MMPs.
With regard to IFN-γ, this cytokine seems to oppositely suppress the development of arthritis because IFN-γ -/-mice were reported to show resistance to antigen-induced arthritis. As generally believed, TNF and IL-6 are pro-inflammatory cytokines, and MMPs are implicated in the degradation and damage of articular cartilage in RA. In CAIA, MMPs are produced by chondrocytes and synoviocytes, as well as macrophages (35) . Specific c-Fms inhibition was reported to potently block TNF release in CAIA (31) . In addition, one report described that 19. Aoki, K., Shimoda, K., Oritani, K., Matsuda, T., Kamezaki, K., Muromoto, R., Numata, A., Tamiya, S., Haro, T., Ishikawa, F., Takase, K., Yamamoto, T., Yumioka, T., Miyamoto, T., Nagafuji, K., Gondo, H., Nagafuchi, S., Nakayama, K., and 
